Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.
Citation: Journal of Clinical Endocrinology & Metabolism. 101(4):1754-61, 2016 AprPMID: 26900641Institution: MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | Multicenter Study | Randomized Controlled TrialSubject headings: *Anemia/ci [Chemically Induced] | *Diabetes Mellitus, Type 2/pc [Prevention & Control] | *Hypoglycemic Agents/ae [Adverse Effects] | *Metformin/ae [Adverse Effects] | *Vitamin B 12 Deficiency/ci [Chemically Induced] | Adult | Aged | Female | Homocysteine/bl [Blood] | Humans | Hypoglycemic Agents/tu [Therapeutic Use] | Male | Metformin/tu [Therapeutic Use] | Middle Aged | Vitamin B 12/bl [Blood]Year: 2016Local holdings: Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006ISSN:- 0021-972X
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 26900641 | Available | 26900641 |
Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006
Participants from DPP/DPPOS were assigned to placebo (n=1082) or metformin (n=1073) for 3.2 years, followed by metformin in the metformin group for 9 years. Metformin use was associated with increased risk of vitamin B12 deficiency.
English